Utilizing AI to accelerate research and development for drug discovery and biological studies. MELVILLE, NY - Nikon Corporation (Nikon) has announced the release of the smart imaging system “ECLIPSE Ji”, which utilizes AI to automate the acquisition and analysis of cellular images, streamlining research workflows involving cancer and nerve disease. The smart imaging system “ECLIPSE [...]

Partnership will satisfy growing need among biopharma and life science companies for end-to-end solutions so customers can focus on science RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, has entered into an agreement with Tobin [...]

Hamilton, Integra, Revvity, and Tecan Join PacBio Compatible to Offer Verified Automated Library Prep Workflows for Whole Genome Sequencing MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that automation providers Hamilton, Integra, Revvity and Tecan have created fully automated protocols to prepare samples for sequencing on Revio and [...]

BlueWhale Bio Science Team led by world-renowned immunotherapy pioneers Carl June and James Riley of University of Pennsylvania BlueWhale Bio technology platform aims to bring cell and gene therapy benefits to patients faster and at lower cost Investors include Danaher Ventures, Novalis LifeSciences, Marshall Wace, Hillhouse Capital PHILADELPHIA -- BlueWhale Bio, Inc., a new company spun out of the University of Pennsylvania to [...]

SAN DIEGO-- Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the promotion of Ryan Bernhardt to the position of Chief Executive Officer. Mr. Bernhardt previously served as the company’s Chief Commercial Officer. Tom Gilman, Biosero’s founding CEO and president, will work closely with Mr. Bernhardt through September 30, 2023 to transition [...]

WALTHAM, Mass.-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the National Minority Quality Forum (NMQF), an independent not-for-profit research and education organization, today announced a collaboration to help bring clinical research to historically underserved patient populations through NMQF’s Alliance for Representative Clinical Trials (ARC). The collaboration supports biopharmaceutical and [...]

Macrogen, Inc., Propath UK, and Sirona Dx Add CosMx Spatial Molecular Imager to Meet Growing Demand for Spatial Biology Tools for Drug Developers SEATTLE-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today three new Contract Research Organization (CRO) CosMxTM Spatial Molecular Imager partnerships. Macrogen, Propath UK, [...]

Gussin brings over 20 years of innovation and product development expertise within diagnostics and life sciences to spearhead BioFlyte’s product roadmap and commercialization efforts ALBUQUERQUE, N.M.— BioFlyte, a bioaerosol surveillance firm with a disruptive new class of fieldable biological threat collection, detection, and identification solutions, today announced the appointment of Daniel (Dan) Gussin as Vice President [...]

FARMINGDALE, NY  --  Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023, with Enzo’s Chief Operating Officer, Kara Cannon, assuming the role of interim CEO. “We thank Hamid for the commitment he [...]

Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including Brazil in the exclusive collaboration and distribution agreement for Devyser's post-transplant portfolio of NGS products. In addition to North America and Europe, Thermo Fisher will now exclusively market and sell Devyser's transplantation products under combined brands also in Brazil.   "We are very [...]